Genetic basis of rheumatoid arthritis: A current review

Biochemical and Biophysical Research Communications

Volumn 452, Issue 2, 2014, Pages 254-262

  Kochi, Yuta ^a   Suzuki, Akari ^a   Yamamoto, Kazuhiko ^a,b  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti citrullinated protein antibody; Genome wide association study; HLA DRB1; Rheumatoid arthritis

Indexed keywords

CHEMOKINE RECEPTOR CCR6; HLA DRB1 ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PAD14 PROTEIN; PROTEIN; STAT4 PROTEIN; TNFAIP3 PROTEIN; UNCLASSIFIED DRUG; CCR6 PROTEIN, HUMAN; DNA BINDING PROTEIN; HYDROLASE; NUCLEAR PROTEIN; PEPTIDYLARGININE DEIMINASE TYPE IV; PTPN22 PROTEIN, HUMAN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

CLINICAL PRACTICE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HERITABILITY; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; ANTI-CITRULLINATED PROTEIN ANTIBODY; GENETICS; RISK;

ANTI-CITRULLINATED PROTEIN ANTIBODY; GENOME-WIDE ASSOCIATION STUDY; HLA-DRB1; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; DNA-BINDING PROTEINS; GENOME-WIDE ASSOCIATION STUDY; HLA-DRB1 CHAINS; HUMANS; HYDROLASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RECEPTORS, CCR6; RISK; STAT4 TRANSCRIPTION FACTOR;

EID: 84908615900     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.085     Document Type: Review

References (88)

1. D. Aletaha, T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham 3rd, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, M.D. Cohen, B. Combe, K.H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J.M. Hazes, K. Hobbs, T.W. Huizinga, A. Kavanaugh, J. Kay, T.K. Kvien, T. Laing, P. Mease, H.A. Menard, L.W. Moreland, R.L. Naden, T. Pincus, J.S. Smolen, E. Stanislawska-Biernat, D. Symmons, P.P. Tak, K.S. Upchurch, J. Vencovsky, F. Wolfe, G. Hawker, Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum. 62 (2010) (2010) 2569-2581.
2. G.A. Schellekens, B.A. de Jong, F.H. van den Hoogen, L.B. van de Putte, W.J. van Venrooij, Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies, J. Clin. Invest. 101 (1998) 273-281.
3. T. Frisell, M. Holmqvist, H. Kallberg, L. Klareskog, L. Alfredsson, J. Askling, Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age, Arthritis Rheum. 65 (2013) 2773-2782.
4. A.J. Silman, A.J. MacGregor, W. Thomson, S. Holligan, D. Carthy, A. Farhan, W.E. Ollier, Twin concordance rates for rheumatoid arthritis: results from a nationwide study, Br. J. Rheumatol. 32 (1993) 903-907.
5. A.J. MacGregor, H. Snieder, A.S. Rigby, M. Koskenvuo, J. Kaprio, K. Aho, A.J. Silman, Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins, Arthritis Rheum. 43 (2000) 30-37.
6. D. van der Woude, J.J. Houwing-Duistermaat, R.E. Toes, T.W. Huizinga, W. Thomson, J. Worthington, A.H. van der Helm-van Mil, R.R. de Vries, Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis, Arthritis Rheum. 60 (2009) 916-923.
7. International HapMap Consortium, The International HapMap Project, Nature 426 (2003) 789-796.
8. K.P. Liao, L. Alfredsson, E.W. Karlson, Environmental influences on risk for rheumatoid arthritis, Curr. Opin. Rheumatol. 21 (2009) 279-283.
9. R.A. Hoovestol, T.R. Mikuls, Environmental exposures and rheumatoid arthritis risk, Curr. Rheumatol. Rep. 13 (2011) 431-439.
10. G.P. Astorga, R.C. Williams Jr., Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis, Arthritis Rheum. 12 (1969) 547-554.
11. A.J. McMichael, T. Sasazuki, H.O. McDevitt, R.O. Payne, Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis, Arthritis Rheum. 20 (1977) 1037-1042.
12. P. Stastny, Association of the B-cell alloantigen DRw4 with rheumatoid arthritis, N. Engl. J. Med. 298 (1978) 869-871.
13. L. Legrand, G.M. Lathrop, A. Marcelli-Barge, A. Dryll, T. Bardin, N. Debeyre, J.C. Poirier, M. Schmid, A. Ryckewaert, J. Dausset, HLA-DR genotype risks in seropositive rheumatoid arthritis, Am. J. Hum. Genet. 36 (1984) 690-699.
14. P.K. Gregersen, J. Silver, R.J. Winchester, The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum. 30 (1987) 1205-1213.
15. B.M. Freed, R.P. Schuyler, M.T. Aubrey, Association of the HLA-DRB1 epitope LA(67, 74) with rheumatoid arthritis and citrullinated vimentin binding, Arthritis Rheum. 63 (2011) 3733-3739.
16. S. Raychaudhuri, C. Sandor, E.A. Stahl, J. Freudenberg, H.S. Lee, X. Jia, L. Alfredsson, L. Padyukov, L. Klareskog, J. Worthington, K.A. Siminovitch, S.C. Bae, R.M. Plenge, P.K. Gregersen, P.I. de Bakker, Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis, Nat. Genet. 44 (2012) 291-296.
17. I. Auger, M. Sebbag, C. Vincent, N. Balandraud, S. Guis, L. Nogueira, B. Svensson, A. Cantagrel, G. Serre, J. Roudier, Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen, Arthritis Rheum. 52 (2005) 3424-3432.
18. F.A. van Gaalen, J. van Aken, T.W. Huizinga, G.M. Schreuder, F.C. Breedveld, E. Zanelli, W.J. van Venrooij, C.L. Verweij, R.E. Toes, R.R. de Vries, Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis, Arthritis Rheum. 50 (2004) 2113-2121.
19. S. Bas, T.V. Perneger, E. Mikhnevitch, M. Seitz, J.M. Tiercy, P. Roux-Lombard, P.A. Guerne, Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis, Rheumatology (Oxford) 39 (2000) 1082-1088.
20. K. Shimane, Y. Kochi, A. Suzuki, Y. Okada, T. Ishii, T. Horita, K. Saito, A. Okamoto, N. Nishimoto, K. Myouzen, M. Kubo, M. Hirakata, T. Sumida, Y. Takasaki, R. Yamada, Y. Nakamura, N. Kamatani, K. Yamamoto, An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of ∗09:01 allele on disease phenotypes, Rheumatology (Oxford) 52 (2013) 1172-1182.
21. J.A. Hill, S. Southwood, A. Sette, A.M. Jevnikar, D.A. Bell, E. Cairns, Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1∗0401 MHC class II molecule, J. Immunol. 171 (2003) 538-541.
22. S.W. Scally, J. Petersen, S.C. Law, N.L. Dudek, H.J. Nel, K.L. Loh, L.C. Wijeyewickrema, S.B. Eckle, J. van Heemst, R.N. Pike, J. McCluskey, R.E. Toes, N.L. La Gruta, A.W. Purcell, H.H. Reid, R. Thomas, J. Rossjohn, A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis, J. Exp. Med. 210 (2013) 2569-2582.
23. L. Klareskog, J. Ronnelid, K. Lundberg, L. Padyukov, L. Alfredsson, Immunity to citrullinated proteins in rheumatoid arthritis, Annu. Rev. Immunol. 26 (2008) 651-675.
24. D. van der Woude, S. Rantapaa-Dahlqvist, A. Ioan-Facsinay, C. Onnekink, C.M. Schwarte, K.N. Verpoort, J.W. Drijfhout, T.W. Huizinga, R.E. Toes, G.J. Pruijn, Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis, Ann. Rheum. Dis. 69 (2010) 1554-1561.
25. L. Klareskog, P. Stolt, K. Lundberg, H. Kallberg, C. Bengtsson, J. Grunewald, J. Ronnelid, H.E. Harris, A.K. Ulfgren, S. Rantapaa-Dahlqvist, A. Eklund, L. Padyukov, L. Alfredsson, A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination, Arthritis Rheum. 54 (2006) 38-46.
26. S.P. Linn-Rasker, A.H. van der Helm-van Mil, F.A. van Gaalen, M. Kloppenburg, R.R. de Vries, S. le Cessie, F.C. Breedveld, R.E. Toes, T.W. Huizinga, Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles, Ann. Rheum. Dis. 65 (2006) 366-371.
27. H. Kallberg, L. Padyukov, R.M. Plenge, J. Ronnelid, P.K. Gregersen, A.H. van der Helm-van Mil, R.E. Toes, T.W. Huizinga, L. Klareskog, L. Alfredsson, Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis, Am. J. Hum. Genet. 80 (2007) 867-875.
28. K. Lundberg, C. Bengtsson, N. Kharlamova, E. Reed, X. Jiang, H. Kallberg, I. Pollak-Dorocic, L. Israelsson, C. Kessel, L. Padyukov, R. Holmdahl, L. Alfredsson, L. Klareskog, Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile, Ann. Rheum. Dis. 72 (2013) 652-658.
29. H. Mahdi, B.A. Fisher, H. Kallberg, D. Plant, V. Malmstrom, J. Ronnelid, P. Charles, B. Ding, L. Alfredsson, L. Padyukov, D.P. Symmons, P.J. Venables, L. Klareskog, K. Lundberg, Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis, Nat. Genet. 41 (2009) 1319-1324.
30. K.N. Verpoort, F.A. van Gaalen, A.H. van der Helm-van Mil, G.M. Schreuder, F.C. Breedveld, T.W. Huizinga, R.R. de Vries, R.E. Toes, Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis, Arthritis Rheum. 52 (2005) 3058-3062.
31. P. Irigoyen, A.T. Lee, M.H. Wener, W. Li, M. Kern, F. Batliwalla, R.F. Lum, E. Massarotti, M. Weisman, C. Bombardier, E.F. Remmers, D.L. Kastner, M.F. Seldin, L.A. Criswell, P.K. Gregersen, Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles, Arthritis Rheum. 52 (2005) 3813-3818.
32. C. Terao, K. Ohmura, K. Ikari, Y. Kochi, E. Maruya, M. Katayama, K. Yurugi, K. Shimada, A. Murasawa, S. Honjo, K. Takasugi, K. Matsuo, K. Tajima, A. Suzuki, K. Yamamoto, S. Momohara, H. Yamanaka, R. Yamada, H. Saji, F. Matsuda, T. Mimori, ACPA-negative RA consists of two genetically distinct subsets based on RF positivity in Japanese, PLoS One 7 (2012) e40067.
33. B. Han, D. Diogo, S. Eyre, H. Kallberg, A. Zhernakova, J. Bowes, L. Padyukov, Y. Okada, M.A. Gonzalez-Gay, S. Rantapaa-Dahlqvist, J. Martin, T.W. Huizinga, R.M. Plenge, J. Worthington, P.K. Gregersen, L. Klareskog, P.I. de Bakker, S. Raychaudhuri, Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity, Am. J. Hum. Genet. 94 (2014) 522-532.
34. A. Suzuki, R. Yamada, X. Chang, S. Tokuhiro, T. Sawada, M. Suzuki, M. Nagasaki, M. Nakayama-Hamada, R. Kawaida, M. Ono, M. Ohtsuki, H. Furukawa, S. Yoshino, M. Yukioka, S. Tohma, T. Matsubara, S. Wakitani, R. Teshima, Y. Nishioka, A. Sekine, A. Iida, A. Takahashi, T. Tsunoda, Y. Nakamura, K. Yamamoto, Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis, Nat. Genet. 34 (2003) 395-402.
35. Wellcome Trust Case Control Consortium, Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls, Nature 447 (2007) 661-678.
36. W. Thomson, A. Barton, X. Ke, S. Eyre, A. Hinks, J. Bowes, R. Donn, D. Symmons, S. Hider, I.N. Bruce, A.G. Wilson, I. Marinou, A. Morgan, P. Emery, A. Carter, S. Steer, L. Hocking, D.M. Reid, P. Wordsworth, P. Harrison, D. Strachan, J. Worthington, Rheumatoid arthritis association at 6q23, Nat. Genet. 39 (2007) 1431-1433.
37. R.M. Plenge, M. Seielstad, L. Padyukov, A.T. Lee, E.F. Remmers, B. Ding, A. Liew, H. Khalili, A. Chandrasekaran, L.R. Davies, W. Li, A.K. Tan, C. Bonnard, R.T. Ong, A. Thalamuthu, S. Pettersson, C. Liu, C. Tian, W.V. Chen, J.P. Carulli, E.M. Beckman, D. Altshuler, L. Alfredsson, L.A. Criswell, C.I. Amos, M.F. Seldin, D.L. Kastner, L. Klareskog, P.K. Gregersen, TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study, N. Engl. J. Med. 357 (2007) 1199-1209.
38. P.K. Gregersen, C.I. Amos, A.T. Lee, Y. Lu, E.F. Remmers, D.L. Kastner, M.F. Seldin, L.A. Criswell, R.M. Plenge, V.M. Holers, T.R. Mikuls, T. Sokka, L.W. Moreland, S.L. Bridges Jr., G. Xie, A.B. Begovich, K.A. Siminovitch, REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis, Nat. Genet. 41 (2009) 820-823.
39. Y. Kochi, Y. Okada, A. Suzuki, K. Ikari, C. Terao, A. Takahashi, K. Yamazaki, N. Hosono, K. Myouzen, T. Tsunoda, N. Kamatani, T. Furuichi, S. Ikegawa, K. Ohmura, T. Mimori, F. Matsuda, T. Iwamoto, S. Momohara, H. Yamanaka, R. Yamada, M. Kubo, Y. Nakamura, K. Yamamoto, A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility, Nat. Genet. 42 (2010) 515-519.
40. E.A. Stahl, S. Raychaudhuri, E.F. Remmers, G. Xie, S. Eyre, B.P. Thomson, Y. Li, F.A. Kurreeman, A. Zhernakova, A. Hinks, C. Guiducci, R. Chen, L. Alfredsson, C.I. Amos, K.G. Ardlie, A. Barton, J. Bowes, E. Brouwer, N.P. Burtt, J.J. Catanese, J. Coblyn, M.J. Coenen, K.H. Costenbader, L.A. Criswell, J.B. Crusius, J. Cui, P.I. de Bakker, P.L. De Jager, B. Ding, P. Emery, E. Flynn, P. Harrison, L.J. Hocking, T.W. Huizinga, D.L. Kastner, X. Ke, A.T. Lee, X. Liu, P. Martin, A.W. Morgan, L. Padyukov, M.D. Posthumus, T.R. Radstake, D.M. Reid, M. Seielstad, M.F. Seldin, N.A. Shadick, S. Steer, P.P. Tak, W. Thomson, A.H. van der Helm-van Mil, I.E. van der Horst-Bruinsma, C.E. van der Schoot, P.L. van Riel, M.E. Weinblatt, A.G. Wilson, G.J. Wolbink, B.P. Wordsworth, C. Wijmenga, E.W. Karlson, R.E. Toes, N. de Vries, A.B. Begovich, J. Worthington, K.A. Siminovitch, P.K. Gregersen, L. Klareskog, R.M. Plenge, Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci, Nat. Genet. 42 (2010) 508-514.
41. Y. Okada, C. Terao, K. Ikari, Y. Kochi, K. Ohmura, A. Suzuki, T. Kawaguchi, E.A. Stahl, F.A. Kurreeman, N. Nishida, H. Ohmiya, K. Myouzen, M. Takahashi, T. Sawada, Y. Nishioka, M. Yukioka, T. Matsubara, S. Wakitani, R. Teshima, S. Tohma, K. Takasugi, K. Shimada, A. Murasawa, S. Honjo, K. Matsuo, H. Tanaka, K. Tajima, T. Suzuki, T. Iwamoto, Y. Kawamura, H. Tanii, Y. Okazaki, T. Sasaki, P.K. Gregersen, L. Padyukov, J. Worthington, K.A. Siminovitch, M. Lathrop, A. Taniguchi, A. Takahashi, K. Tokunaga, M. Kubo, Y. Nakamura, N. Kamatani, T. Mimori, R.M. Plenge, H. Yamanaka, S. Momohara, R. Yamada, F. Matsuda, K. Yamamoto, Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population, Nat. Genet. 44 (2012) 511-516.
42. Y. Okada, D. Wu, G. Trynka, T. Raj, C. Terao, K. Ikari, Y. Kochi, K. Ohmura, A. Suzuki, S. Yoshida, R.R. Graham, A. Manoharan, W. Ortmann, T. Bhangale, J.C. Denny, R.J. Carroll, A.E. Eyler, J.D. Greenberg, J.M. Kremer, D.A. Pappas, L. Jiang, J. Yin, L. Ye, D.F. Su, J. Yang, G. Xie, E. Keystone, H.J. Westra, T. Esko, A. Metspalu, X. Zhou, N. Gupta, D. Mirel, E.A. Stahl, D. Diogo, J. Cui, K. Liao, M.H. Guo, K. Myouzen, T. Kawaguchi, M.J. Coenen, P.L. van Riel, M.A. van de Laar, H.J. Guchelaar, T.W. Huizinga, P. Dieude, X. Mariette, S.L. Bridges Jr., A. Zhernakova, R.E. Toes, P.P. Tak, C. Miceli-Richard, S.Y. Bang, H.S. Lee, J. Martin, M.A. Gonzalez-Gay, L. Rodriguez-Rodriguez, S. Rantapaa-Dahlqvist, L. Arlestig, H.K. Choi, Y. Kamatani, P. Galan, M. Lathrop, R. consortium, G. consortium, S. Eyre, J. Bowes, N. de Vries, L.W. Moreland, L.A. Criswell, E.W. Karlson, A. Taniguchi, R. Yamada, M. Kubo, J.S. Liu, S.C. Bae, J. Worthington, L. Padyukov, L. Klareskog, P.K. Gregersen, S. Raychaudhuri, B.E. Stranger, P.L. De Jager, L. Franke, P.M. Visscher, M.A. Brown, H. Yamanaka, T. Mimori, A. Takahashi, H. Xu, T.W. Behrens, K.A. Siminovitch, S. Momohara, F. Matsuda, K. Yamamoto, R.M. Plenge, Genetics of rheumatoid arthritis contributes to biology and drug discovery, Nature 506 (2014) 376-381.
43. H.J. Westra, M.J. Peters, T. Esko, H. Yaghootkar, C. Schurmann, J. Kettunen, M.W. Christiansen, B.P. Fairfax, K. Schramm, J.E. Powell, A. Zhernakova, D.V. Zhernakova, J.H. Veldink, L.H. Van den Berg, J. Karjalainen, S. Withoff, A.G. Uitterlinden, A. Hofman, F. Rivadeneira, P.A. t Hoen, E. Reinmaa, K. Fischer, M. Nelis, L. Milani, D. Melzer, L. Ferrucci, A.B. Singleton, D.G. Hernandez, M.A. Nalls, G. Homuth, M. Nauck, D. Radke, U. Volker, M. Perola, V. Salomaa, J. Brody, A. Suchy-Dicey, S.A. Gharib, D.A. Enquobahrie, T. Lumley, G.W. Montgomery, S. Makino, H. Prokisch, C. Herder, M. Roden, H. Grallert, T. Meitinger, K. Strauch, Y. Li, R.C. Jansen, P.M. Visscher, J.C. Knight, B.M. Psaty, S. Ripatti, A. Teumer, T.M. Frayling, A. Metspalu, J.B. van Meurs, L. Franke, Systematic identification of trans eQTLs as putative drivers of known disease associations, Nat. Genet. 45 (2013) 1238-1243.
44. P.C. Dubois, G. Trynka, L. Franke, K.A. Hunt, J. Romanos, A. Curtotti, A. Zhernakova, G.A. Heap, R. Adany, A. Aromaa, M.T. Bardella, L.H. van den Berg, N.A. Bockett, E.G. de la Concha, B. Dema, R.S. Fehrmann, M. Fernandez-Arquero, S. Fiatal, E. Grandone, P.M. Green, H.J. Groen, R. Gwilliam, R.H. Houwen, S.E. Hunt, K. Kaukinen, D. Kelleher, I. Korponay-Szabo, K. Kurppa, P. MacMathuna, M. Maki, M.C. Mazzilli, O.T. McCann, M.L. Mearin, C.A. Mein, M.M. Mirza, V. Mistry, B. Mora, K.I. Morley, C.J. Mulder, J.A. Murray, C. Nunez, E. Oosterom, R.A. Ophoff, I. Polanco, L. Peltonen, M. Platteel, A. Rybak, V. Salomaa, J.J. Schweizer, M.P. Sperandeo, G.J. Tack, G. Turner, J.H. Veldink, W.H. Verbeek, R.K. Weersma, V.M. Wolters, E. Urcelay, B. Cukrowska, L. Greco, S.L. Neuhausen, R. McManus, D. Barisani, P. Deloukas, J.C. Barrett, P. Saavalainen, C. Wijmenga, D.A. van Heel, Multiple common variants for celiac disease influencing immune gene expression, Nat. Genet. 42 (2010) 295-302.
45. Y. Okada, K. Shimane, Y. Kochi, T. Tahira, A. Suzuki, K. Higasa, A. Takahashi, T. Horita, T. Atsumi, T. Ishii, A. Okamoto, K. Fujio, M. Hirakata, H. Amano, Y. Kondo, S. Ito, K. Takada, A. Mimori, K. Saito, M. Kamachi, Y. Kawaguchi, K. Ikari, O.W. Mohammed, K. Matsuda, C. Terao, K. Ohmura, K. Myouzen, N. Hosono, T. Tsunoda, N. Nishimoto, T. Mimori, F. Matsuda, Y. Tanaka, T. Sumida, H. Yamanaka, Y. Takasaki, T. Koike, T. Horiuchi, K. Hayashi, M. Kubo, N. Kamatani, R. Yamada, Y. Nakamura, K. Yamamoto, A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus erythematosus in Japanese, PLoS Genet. 8 (2012) e1002455.
46. E.P. Consortium, A. Kundaje, S.F. Aldred, P.J. Collins, C.A. Davis, F. Doyle, C.B. Epstein, S. Frietze, J. Harrow, R. Kaul, J. Khatun, B.R. Lajoie, S.G. Landt, B.K. Lee, F. Pauli, K.R. Rosenbloom, P. Sabo, A. Safi, A. Sanyal, N. Shoresh, J.M. Simon, L. Song, N.D. Trinklein, R.C. Altshuler, E. Birney, J.B. Brown, C. Cheng, S. Djebali, X. Dong, J. Ernst, T.S. Furey, M. Gerstein, B. Giardine, M. Greven, R.C. Hardison, R.S. Harris, J. Herrero, M.M. Hoffman, S. Iyer, M. Kelllis, P. Kheradpour, T. Lassmann, Q. Li, X. Lin, G.K. Marinov, A. Merkel, A. Mortazavi, S.C. Parker, T.E. Reddy, J. Rozowsky, F. Schlesinger, R.E. Thurman, J. Wang, L.D. Ward, T.W. Whitfield, S.P. Wilder, W. Wu, H.S. Xi, K.Y. Yip, J. Zhuang, B.E. Bernstein, E.D. Green, C. Gunter, M. Snyder, M.J. Pazin, R.F. Lowdon, L.A. Dillon, L.B. Adams, C.J. Kelly, J. Zhang, J.R. Wexler, P.J. Good, E.A. Feingold, G.E. Crawford, J. Dekker, L. Elinitski, P.J. Farnham, M.C. Giddings, T.R. Gingeras, R. Guigo, T.J. Hubbard, M. Kellis, W.J. Kent, J.D. Lieb, E.H. Margulies, R.M. Myers, J.A. Starnatoyannopoulos, S.A. Tennebaum, Z. Weng, K.P. White, B. Wold, Y. Yu, J. Wrobel, B.A. Risk, H.P. Gunawardena, H.C. Kuiper, C.W. Maier, L. Xie, X. Chen, et al., An integrated encyclopedia of DNA elements in the human genome, Nature 489 (2012) 57-74.
47. G. Trynka, C. Sandor, B. Han, H. Xu, B.E. Stranger, X.S. Liu, S. Raychaudhuri, Chromatin marks identify critical cell types for fine mapping complex trait variants, Nat. Genet. 45 (2013) 124-130.
48. Y. Kochi, A. Suzuki, R. Yamada, K. Yamamoto, Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis, Nat. Rev. Rheumatol. 6 (2010) 290-295.
49. Y. Kochi, M.M. Thabet, A. Suzuki, Y. Okada, N.A. Daha, R.E. Toes, T.W. Huizinga, K. Myouzen, M. Kubo, R. Yamada, Y. Nakamura, K. Yamamoto, PADI4 polymorphism predisposes male smokers to rheumatoid arthritis, Ann. Rheum. Dis. 70 (2011) 512-515.
50. A.B. Begovich, V.E. Carlton, L.A. Honigberg, S.J. Schrodi, A.P. Chokkalingam, H.C. Alexander, K.G. Ardlie, Q. Huang, A.M. Smith, J.M. Spoerke, M.T. Conn, M. Chang, S.Y. Chang, R.K. Saiki, J.J. Catanese, D.U. Leong, V.E. Garcia, L.B. McAllister, D.A. Jeffery, A.T. Lee, F. Batliwalla, E. Remmers, L.A. Criswell, M.F. Seldin, D.L. Kastner, C.I. Amos, J.J. Sninsky, P.K. Gregersen, A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis, Am. J. Hum. Genet. 75 (2004) 330-337.
51. J. Zheng, S. Ibrahim, F. Petersen, X. Yu, Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue, Genes Immun. 13 (2012) 641-652.
52. M. Mori, R. Yamada, K. Kobayashi, R. Kawaida, K. Yamamoto, Ethnic differences in allele frequency of autoimmune-disease-associated SNPs, J. Hum. Genet. 50 (2005) 264-266.
53. T.C. Lins, R.G. Vieira, D. Grattapaglia, R.W. Pereira, Allele and haplotype frequency distribution in PTPN22 gene across variable ethnic groups: Implications for genetic association studies for autoimmune diseases, Autoimmunity 43 (2010) 308-316.
54. A.F. Arechiga, T. Habib, Y. He, X. Zhang, Z.Y. Zhang, A. Funk, J.H. Buckner, Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling, J. Immunol. 182 (2009) 3343-3347.
55. T. Vang, M. Congia, M.D. Macis, L. Musumeci, V. Orru, P. Zavattari, K. Nika, L. Tautz, K. Tasken, F. Cucca, T. Mustelin, N. Bottini, Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant, Nat. Genet. 37 (2005) 1317-1319.
56. J. Zhang, N. Zahir, Q. Jiang, H. Miliotis, S. Heyraud, X. Meng, B. Dong, G. Xie, F. Qiu, Z. Hao, C.A. McCulloch, E.C. Keystone, A.C. Peterson, K.A. Siminovitch, The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness, Nat. Genet. 43 (2011) 902-907.
57. X. Dai, R.G. James, T. Habib, S. Singh, S. Jackson, S. Khim, R.T. Moon, D. Liggitt, A. Wolf-Yadlin, J.H. Buckner, D.J. Rawlings, A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models, J. Clin. Invest. 123 (2013) 2024-2036.
58. J. Zheng, F. Petersen, X. Yu, The role of PTPN22 in autoimmunity: learning from mice, Autoimmun. Rev. 13 (2014) 266-271.
59. R.R. Graham, C. Cotsapas, L. Davies, R. Hackett, C.J. Lessard, J.M. Leon, N.P. Burtt, C. Guiducci, M. Parkin, C. Gates, R.M. Plenge, T.W. Behrens, J.E. Wither, J.D. Rioux, P.R. Fortin, D.C. Graham, A.K. Wong, T.J. Vyse, M.J. Daly, D. Altshuler, K.L. Moser, P.M. Gaffney, Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus, Nat. Genet. 40 (2008) 1059-1061.
60. S.L. Musone, K.E. Taylor, T.T. Lu, J. Nititham, R.C. Ferreira, W. Ortmann, N. Shifrin, M.A. Petri, M. Ilyas Kamboh, S. Manzi, M.F. Seldin, P.K. Gregersen, T.W. Behrens, A. Ma, P.Y. Kwok, L.A. Criswell, Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus, Nat. Genet. 40 (2008) 1062-1064.
61. I. Adrianto, F. Wen, A. Templeton, G. Wiley, J.B. King, C.J. Lessard, J.S. Bates, Y. Hu, J.A. Kelly, K.M. Kaufman, J.M. Guthridge, M.E. Alarcon-Riquelme, Biolupus, G. Networks, J.M. Anaya, S.C. Bae, S.Y. Bang, S.A. Boackle, E.E. Brown, M.A. Petri, C. Gallant, R. Ramsey-Goldman, J.D. Reveille, L.M. Vila, L.A. Criswell, J.C. Edberg, B.I. Freedman, P.K. Gregersen, G.S. Gilkeson, C.O. Jacob, J.A. James, D.L. Kamen, R.P. Kimberly, J. Martin, J.T. Merrill, T.B. Niewold, S.Y. Park, B.A. Pons-Estel, R.H. Scofield, A.M. Stevens, B.P. Tsao, T.J. Vyse, C.D. Langefeld, J.B. Harley, K.L. Moser, C.F. Webb, M.B. Humphrey, C.G. Montgomery, P.M. Gaffney, Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus, Nat. Genet. 43 (2011) 253-258.
62. M. Matmati, P. Jacques, J. Maelfait, E. Verheugen, M. Kool, M. Sze, L. Geboes, E. Louagie, C. Mc Guire, L. Vereecke, Y. Chu, L. Boon, S. Staelens, P. Matthys, B.N. Lambrecht, M. Schmidt-Supprian, M. Pasparakis, D. Elewaut, R. Beyaert, G. van Loo, A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis, Nat. Genet. 43 (2011) 908-912.
63. M. Kato, M. Sanada, I. Kato, Y. Sato, J. Takita, K. Takeuchi, A. Niwa, Y. Chen, K. Nakazaki, J. Nomoto, Y. Asakura, S. Muto, A. Tamura, M. Iio, Y. Akatsuka, Y. Hayashi, H. Mori, T. Igarashi, M. Kurokawa, S. Chiba, S. Mori, Y. Ishikawa, K. Okamoto, K. Tobinai, H. Nakagama, T. Nakahata, T. Yoshino, Y. Kobayashi, S. Ogawa, Frequent inactivation of A20 in B-cell lymphomas, Nature 459 (2009) 712-716.
64. E.F. Remmers, R.M. Plenge, A.T. Lee, R.R. Graham, G. Hom, T.W. Behrens, P.I. de Bakker, J.M. Le, H.S. Lee, F. Batliwalla, W. Li, S.L. Masters, M.G. Booty, J.P. Carulli, L. Padyukov, L. Alfredsson, L. Klareskog, W.V. Chen, C.I. Amos, L.A. Criswell, M.F. Seldin, D.L. Kastner, P.K. Gregersen, STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus, N. Engl. J. Med. 357 (2007) 977-986.
65. J. Zheng, J. Yin, R. Huang, F. Petersen, X. Yu, Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody, Hum. Immunol. 74 (2013) 986-992.
66. S. Sigurdsson, G. Nordmark, S. Garnier, E. Grundberg, T. Kwan, O. Nilsson, M.L. Eloranta, I. Gunnarsson, E. Svenungsson, G. Sturfelt, A.A. Bengtsson, A. Jonsen, L. Truedsson, S. Rantapaa-Dahlqvist, C. Eriksson, G. Alm, H.H. Goring, T. Pastinen, A.C. Syvanen, L. Ronnblom, A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5, Hum. Mol. Genet. 17 (2008) 2868-2876.
67. S.N. Kariuki, K.A. Kirou, E.J. MacDermott, L. Barillas-Arias, M.K. Crow, T.B. Niewold, Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo, J. Immunol. 182 (2009) 34-38.
68. J.C. Barrett, S. Hansoul, D.L. Nicolae, J.H. Cho, R.H. Duerr, J.D. Rioux, S.R. Brant, M.S. Silverberg, K.D. Taylor, M.M. Barmada, A. Bitton, T. Dassopoulos, L.W. Datta, T. Green, A.M. Griffiths, E.O. Kistner, M.T. Murtha, M.D. Regueiro, J.I. Rotter, L.P. Schumm, A.H. Steinhart, S.R. Targan, R.J. Xavier, C. Libioulle, C. Sandor, M. Lathrop, J. Belaiche, O. Dewit, I. Gut, S. Heath, D. Laukens, M. Mni, P. Rutgeerts, A. Van Gossum, D. Zelenika, D. Franchimont, J.P. Hugot, M. de Vos, S. Vermeire, E. Louis, L.R. Cardon, C.A. Anderson, H. Drummond, E. Nimmo, T. Ahmad, N.J. Prescott, C.M. Onnie, S.A. Fisher, J. Marchini, J. Ghori, S. Bumpstead, R. Gwilliam, M. Tremelling, P. Deloukas, J. Mansfield, D. Jewell, J. Satsangi, C.G. Mathew, M. Parkes, M. Georges, M.J. Daly, Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease, Nat. Genet. 40 (2008) 955-962.
69. L.C. Tsoi, S.L. Spain, J. Knight, E. Ellinghaus, P.E. Stuart, F. Capon, J. Ding, Y. Li, T. Tejasvi, J.E. Gudjonsson, H.M. Kang, M.H. Allen, R. McManus, G. Novelli, L. Samuelsson, J. Schalkwijk, M. Stahle, A.D. Burden, C.H. Smith, M.J. Cork, X. Estivill, A.M. Bowcock, G.G. Krueger, W. Weger, J. Worthington, R. Tazi-Ahnini, F.O. Nestle, A. Hayday, P. Hoffmann, J. Winkelmann, C. Wijmenga, C. Langford, S. Edkins, R. Andrews, H. Blackburn, A. Strange, G. Band, R.D. Pearson, D. Vukcevic, C.C. Spencer, P. Deloukas, U. Mrowietz, S. Schreiber, S. Weidinger, S. Koks, K. Kingo, T. Esko, A. Metspalu, H.W. Lim, J.J. Voorhees, M. Weichenthal, H.E. Wichmann, V. Chandran, C.F. Rosen, P. Rahman, D.D. Gladman, C.E. Griffiths, A. Reis, J. Kere, Collaborative Association Study of Psoriasis, Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium, R.P. Nair, A. Franke, J.N. Barker, G.R. Abecasis, J.T. Elder, R.C. Trembath, Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity, Nat. Genet. 44 (2012) 1341-1348.
70. E. Jakkula, V. Leppa, A.M. Sulonen, T. Varilo, S. Kallio, A. Kemppinen, S. Purcell, K. Koivisto, P. Tienari, M.L. Sumelahti, I. Elovaara, T. Pirttila, M. Reunanen, A. Aromaa, A.B. Oturai, H.B. Sondergaard, H.F. Harbo, I.L. Mero, S.B. Gabriel, D.B. Mirel, S.L. Hauser, L. Kappos, C. Polman, P.L. De Jager, D.A. Hafler, M.J. Daly, A. Palotie, J. Saarela, L. Peltonen, Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene, Am. J. Hum. Genet. 86 (2010) 285-291.
71. K. Hirota, H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, N. Sakaguchi, S. Sakaguchi, Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model, J. Exp. Med. 204 (2007) 2803-2812.
72. N. Komatsu, K. Okamoto, S. Sawa, T. Nakashima, M. Oh-Hora, T. Kodama, S. Tanaka, J.A. Bluestone, H. Takayanagi, Pathogenic conversion of Foxp3(+) T cells into TH17 cells in autoimmune arthritis, Nat. Med. 20 (2014) 62-68.
73. W.Y. Wang, B.J. Barratt, D.G. Clayton, J.A. Todd, Genome-wide association studies: theoretical and practical concerns, Nat. Rev. Genet. 6 (2005) 109-118.
74. E.A. Stahl, D. Wegmann, G. Trynka, J. Gutierrez-Achury, R. Do, B.F. Voight, P. Kraft, R. Chen, H.J. Kallberg, F.A. Kurreeman, Diabetes Genetics Replication and Meta-analysis Consortium, Myocardial Infarction Genetics Consortium, S. Kathiresan, C. Wijmenga, P.K. Gregersen, L. Alfredsson, K.A. Siminovitch, J. Worthington, P.I. de Bakker, S. Raychaudhuri, R.M. Plenge, Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis, Nat. Genet. 44 (2012) 483-489.
75. A. Kiezun, K. Garimella, R. Do, N.O. Stitziel, B.M. Neale, P.J. McLaren, N. Gupta, P. Sklar, P.F. Sullivan, J.L. Moran, C.M. Hultman, P. Lichtenstein, P. Magnusson, T. Lehner, Y.Y. Shugart, A.L. Price, P.I. de Bakker, S.M. Purcell, S.R. Sunyaev, Exome sequencing and the genetic basis of complex traits, Nat. Genet. 44 (2012) 623-630.
76. D. Diogo, F. Kurreeman, E.A. Stahl, K.P. Liao, N. Gupta, J.D. Greenberg, M.A. Rivas, B. Hickey, J. Flannick, B. Thomson, C. Guiducci, S. Ripke, I. Adzhubey, A. Barton, J.M. Kremer, L. Alfredsson, Consortium of Rheumatology Researchers of North America, Rheumatoid Arthritis Consortium International, S. Sunyaev, J. Martin, A. Zhernakova, J. Bowes, S. Eyre, K.A. Siminovitch, P.K. Gregersen, J. Worthington, L. Klareskog, L. Padyukov, S. Raychaudhuri, R.M. Plenge, Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis, Am. J. Hum. Genet. 92 (2013) 15-27.
77. A. MacGregor, W. Ollier, W. Thomson, D. Jawaheer, A. Silman, HLA-DRB1/0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity, J. Rheumatol. 22 (1995) 1032-1036.
78. C.M. Weyand, K.C. Hicok, D.L. Conn, J.J. Goronzy, The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis, Ann. Intern. Med. 117 (1992) 801-806.
79. T. Suzuki, K. Ikari, K. Yano, E. Inoue, Y. Toyama, A. Taniguchi, H. Yamanaka, S. Momohara, PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study, PLoS One 8 (2013) e61045.
80. A. Barton, J. Bowes, S. Eyre, D. Symmons, J. Worthington, A. Silman, Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis, Ann. Rheum. Dis. 64 (2005) 1311-1315.
81. B. Joven, N. Gonzalez, F. Aguilar, B. Santiago, M. Galindo, J. Alcami, J.L. Pablos, Association between stromal cell-derived factor 1 chemokine gene variant and radiographic progression of rheumatoid arthritis, Arthritis Rheum. 52 (2005) 354-356.
82. R. Knevel, A. Krabben, A.G. Wilson, E. Brouwer, M.K. Leijsma, E. Lindqvist, D.P. de Rooy, N.A. Daha, M.P. van der Linden, S. Tsonaka, A. Zhernakova, H.J. Westra, L. Franke, J.J. Houwing-Duistermaat, R.E. Toes, T.W. Huizinga, T. Saxne, A.H. van der Helm-van Mil, A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis, Arthritis Rheum. 65 (2013) 582-589.
83. R.J. Mathews, J.I. Robinson, M. Battellino, C. Wong, J.C. Taylor, G. Biologics in Rheumatoid Arthritis, S. Genomics Study, S. Eyre, S.M. Churchman, A.G. Wilson, J.D. Isaacs, K. Hyrich, A. Barton, D. Plant, S. Savic, G.P. Cook, P. Sarzi-Puttini, P. Emery, J.H. Barrett, A.W. Morgan, M.F. McDermott, Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment, Ann. Rheum. Dis. 73 (2014) 1202-1210.
84. D.P. de Rooy, A. Zhernakova, R. Tsonaka, A. Willemze, B.A. Kurreeman, G. Trynka, L. van Toorn, R.E. Toes, T.W. Huizinga, J.J. Houwing-Duistermaat, P.K. Gregersen, A.H. van der Helm-van Mil, A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis, Ann. Rheum. Dis. 73 (2014) 1163-1169.
85. R. Knevel, K. Klein, K. Somers, C. Ospelt, J.J. Houwing-Duistermaat, J.A. van Nies, D.P. de Rooy, L. de Bock, F.A. Kurreeman, J. Schonkeren, G. Stoeken-Rijsbergen, Q. Helmer, M.P. van der Linden, M. Kern, N. Manjarrez-Orduno, L. Rodriguez-Rodriquez, P. Stinissen, T.W. Huizinga, R.E. Toes, S. Gay, P.K. Gregersen, V. Somers, A.H. van der Helm-van Mil, Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis, Ann. Rheum. Dis. (2013), Available online.
86. C. Liu, F. Batliwalla, W. Li, A. Lee, R. Roubenoff, E. Beckman, H. Khalili, A. Damle, M. Kern, R. Furie, J. Dupuis, R.M. Plenge, M.J. Coenen, T.W. Behrens, J.P. Carulli, P.K. Gregersen, Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis, Mol. Med. 14 (2008) 575-581.
87. D. Plant, J. Bowes, C. Potter, K.L. Hyrich, A.W. Morgan, A.G. Wilson, J.D. Isaacs, Wellcome Trust Case Control Consortium, British Society for Rheumatology Biologics Register, A. Barton, Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci, Arthritis Rheum. 63 (2011) 645-653.
88. J. Cui, E.A. Stahl, S. Saevarsdottir, C. Miceli, D. Diogo, G. Trynka, T. Raj, M.U. Mirkov, H. Canhao, K. Ikari, C. Terao, Y. Okada, S. Wedren, J. Askling, H. Yamanaka, S. Momohara, A. Taniguchi, K. Ohmura, F. Matsuda, T. Mimori, N. Gupta, M. Kuchroo, A.W. Morgan, J.D. Isaacs, A.G. Wilson, K.L. Hyrich, M. Herenius, M.E. Doorenspleet, P.P. Tak, J.B. Crusius, I.E. van der Horst-Bruinsma, G.J. Wolbink, P.L. van Riel, M. van de Laar, H.J. Guchelaar, N.A. Shadick, C.F. Allaart, T.W. Huizinga, R.E. Toes, R.P. Kimberly, S.L. Bridges Jr., L.A. Criswell, L.W. Moreland, J.E. Fonseca, N. de Vries, B.E. Stranger, P.L. De Jager, S. Raychaudhuri, M.E. Weinblatt, P.K. Gregersen, X. Mariette, A. Barton, L. Padyukov, M.J. Coenen, E.W. Karlson, R.M. Plenge, Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis, PLoS Genet. 9 (2013) e1003394.